Breaking news

Digital Services Act Sparks Debate Among Cypriot MEPs: Balancing Safety And Freedom Online

Cypriot MEPs have highlighted the importance of the Digital Services Act (DSA) in creating a safer digital environment across the European Union. However, during a debate at the European Parliament’s plenary session in Strasbourg, they also raised concerns about potential risks to freedom of expression and unintended uses of the legislation.

DISY and EPP MEP Loucas Fourlas praised the Act as a vital step towards robust digital governance, protecting citizens from illegal content, misinformation, and online threats. However, he pointed out that differing views among EU Member States and MEPs illustrate the bloc’s fragmented external policy, which could hinder cohesive action.

Similarly, Michalis Hadjipantela, also from DISY and the EPP, welcomed the Act’s balanced approach, which aims to safeguard users from harmful content while ensuring that smaller businesses are not overburdened. He emphasized its role in fostering a transparent and secure digital ecosystem that supports competition, particularly for SMEs and startups.

From a different perspective, AKEL and Left MEP Giorgos Georgiou criticized the European Commission’s lack of action against the exploitative practices of Big Tech companies. He argued that without addressing the business models of these platforms, which thrive on extreme content, the Act cannot fully tackle hate speech and misinformation. Georgiou called for greater digital sovereignty in Europe, suggesting the development of alternative public platforms like Bluesky or Mastodon to counter Big Tech’s dominance.

DIKO and Progressive Alliance of Socialists and Democrats MEP Costas Mavrides underscored the nuanced nature of freedom of expression, noting that it must operate within the boundaries of EU legal frameworks. He dismissed criticism of restrictions on misinformation as hypocritical, especially from those who advocate for barriers against propaganda from authoritarian regimes.

Conversely, ELAM and European Conservatives and Reformists group MEP Geadis Geadi expressed concerns that the Act risks becoming a tool for censorship, threatening the very freedoms it seeks to protect. He argued for a reassessment of its implementation to ensure users’ rights remain intact.

Independent MEP Fidias Panayiotou echoed these concerns, citing recent accusations by Meta’s Mark Zuckerberg and Elon Musk, owner of platform X, that the EU is institutionalizing censorship. Panayiotou warned against unfairly censoring posts under the guise of misinformation and proposed inviting the tech leaders to the European Parliament for discussions on content moderation practices.

The debate was notable for its high level of engagement, with around 150 MEPs participating—nearly three times the usual attendance. A pilot system was also trialed, where speakers were announced during the session rather than in advance, resulting in lively exchanges and increased interaction through blue cards and petitions.

As the Digital Services Act moves forward, the challenge will lie in striking the right balance between ensuring online safety and safeguarding fundamental freedoms, a debate that will undoubtedly shape the digital future of Europe.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

eCredo
Aretilaw firm
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter